+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Artificial Pancreas Device Systems (APDS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

  • ID: 5009137
  • Report
  • March 2020
  • Region: Global
  • 106 pages
  • IMARC Group
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Beta Bionics Inc.
  • Bigfoot Biomedical Inc.
  • Cellnovo Limited
  • Dexcom Inc.
  • Inreda Diabetic B.V.
  • Insulet Corporation
  • MORE
The global artificial pancreas device systems market is currently experiencing robust growth. APDS refers to a closed-loop or automated insulin delivery system that manages blood glucose levels by regulating the production of insulin. It consists of a continuous glucose monitor (CGM), a subcutaneous insulin infusion pump and a controller that links the monitor with the pump. It runs a complex algorithm that determines the adequate levels of insulin and time of delivery based on the evaluation of real-time glucose readings. It is primarily used to minimize the risks of extreme fluctuations of glucose levels in the body.

The increasing prevalence of pancreatic cancer, pancreatitis and other chronic ailments is one of the key factors driving the growth of the market. Furthermore, the growing occurrence of diabetes and obesity, due to age-related factors, physical inactivity and unhealthy dietary patterns, is also contributing to the widespread adoption of APDS across the globe. The rising demand for efficient diabetes monitoring and minimally invasive (MI) drug delivery systems is also providing a boost to the market growth. APDS automatically monitors the glucose levels and administers doses of insulin throughout the day in controlled amounts. Various technological innovations, including the development of software-based wireless systems that are integrated with automated controls, are further contributing to the market growth. Moreover, regulatory bodies and governments of various nations are significantly investing in research and development (R&D) for the improvement of healthcare infrastructure across the globe. For instance, the Food and Drug Association (US FDA) in the United States is approving an increasing number of new and innovative products, which is creating a positive outlook for the market in the country. Looking forward, the publisher expects the market to exhibit a CAGR of around 18% during 2020-2025.

Breakup by Device Type:

Threshold Suspend Device Systems
Control-to-Range Systems
Control-to-Target Systems

Breakup by Treatment Type:

Bi-hormonal
Insulin Only
Hybrid

Breakup by End-User:

Hospitals
Medical Centres
Others

Breakup by Region:

North America

United States
Canada

Asia Pacific

China
Japan
India
South Korea
Australia
Indonesia
Others

Europe

Germany
France
United Kingdom
Italy
Spain
Russia
Others

Latin America

Brazil
Mexico
Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Beta Bionics Inc., Bigfoot Biomedical Inc., Cellnovo Limited, Dexcom Inc., Inreda Diabetic B.V., Insulet Corporation, Johnson & Johnson, Medtronic Inc., Roche Holding AG, Tandem Diabetes Care Inc., Typezero Technologies Inc., etc.

Key Questions Answered in This Report:
  • How has the global artificial pancreas device systems market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the device type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global artificial pancreas device systems market and who are the key players?
  • What is the degree of competition in the industry?
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Beta Bionics Inc.
  • Bigfoot Biomedical Inc.
  • Cellnovo Limited
  • Dexcom Inc.
  • Inreda Diabetic B.V.
  • Insulet Corporation
  • MORE
1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Artificial Pancreas Device Systems Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Forecast

6 Market Breakup by Device Type
6.1 Threshold Suspend Device Systems
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Control- to-Range Systems
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Control-to-Target Systems
6.3.1 Market Trends
6.3.2 Market Forecast

7 Market Breakup by Treatment Type
7.1 Bi-hormonal
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Insulin Only
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Hybrid
7.3.1 Market Trends
7.3.2 Market Forecast

8 Market Breakup by End-User
8.1 Hospital
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Medical Centres
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast

9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Beta Bionics Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Bigfoot Biomedical Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Cellnovo Limited
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 Dexcom Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Inreda Diabetic B.V.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 Insulet Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Johnson & Johnson
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Medtronic Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Roche Holding AG
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Tandem Diabetes Care Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11 Typezero Technologies Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Beta Bionics Inc.
  • Bigfoot Biomedical Inc.
  • Cellnovo Limited
  • Dexcom Inc.
  • Inreda Diabetic B.V.
  • Insulet Corporation
  • Johnson & Johnson
  • Medtronic Inc.
  • Roche Holding AG
  • Tandem Diabetes Care Inc.
  • Typezero Technologies Inc.
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll